Insider Buying: Ultralife (NASDAQ:ULBI) Director Acquires 32,876 Shares of Stock

by · The Cerbat Gem

Ultralife Corporation (NASDAQ:ULBI – Get Free Report) Director Bradford Whitmore purchased 32,876 shares of Ultralife stock in a transaction dated Thursday, May 21st. The shares were purchased at an average cost of $6.13 per share, for a total transaction of $201,529.88. Following the transaction, the director owned 1,974,635 shares in the company, valued at approximately $12,104,512.55. This trade represents a 1.69% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Ultralife Trading Up 6.5%

Shares of ULBI stock traded up $0.42 during trading on Tuesday, hitting $6.86. 141,220 shares of the stock traded hands, compared to its average volume of 47,721. The firm has a market capitalization of $114.29 million, a P/E ratio of -13.72 and a beta of 0.74. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.56 and a quick ratio of 1.23. The firm’s fifty day moving average price is $6.75 and its 200-day moving average price is $6.23. Ultralife Corporation has a 52-week low of $4.90 and a 52-week high of $9.52.

Ultralife (NASDAQ:ULBI – Get Free Report) last released its quarterly earnings results on Friday, May 8th. The technology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.15 by ($0.18). The firm had revenue of $47.45 million for the quarter, compared to analysts’ expectations of $52.40 million. Ultralife had a negative net margin of 4.37% and a positive return on equity of 1.15%.

Institutional Trading of Ultralife

Several institutional investors have recently added to or reduced their stakes in ULBI. Bank of America Corp DE increased its holdings in Ultralife by 30.7% in the 4th quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock valued at $90,000 after purchasing an additional 2,836 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in Ultralife by 1,428.7% in the 1st quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock valued at $82,000 after purchasing an additional 14,287 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Ultralife by 474.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 70,476 shares of the technology company’s stock valued at $633,000 after purchasing an additional 58,211 shares during the last quarter. Walleye Capital LLC increased its holdings in Ultralife by 127.2% in the 2nd quarter. Walleye Capital LLC now owns 31,102 shares of the technology company’s stock valued at $279,000 after purchasing an additional 17,414 shares during the last quarter. Finally, Qube Research & Technologies Ltd acquired a new stake in Ultralife in the 2nd quarter valued at approximately $134,000. Institutional investors and hedge funds own 30.68% of the company’s stock.

Ultralife Company Profile

(Get Free Report)

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.

Further Reading